Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elihu Estey

Showing results (31-40 of 158) with videos related to

Pageof 16
Sort By:
Hematological Oncology|April 3, 2008
Relevance of clinical trials in acute myeloid leukaemiaApostolia M Tsimberidou, Elihu Estey
Cancer Treatment Reviews|April 3, 2003
Adding arabinosylcytosine to idarubicin induction therapy may not improve survival for people with newly diagnosed acute promyelocytic leukaemiaElihu Estey, Miguel A Sanz
Cancer|November 6, 2003
Gemtuzumab ozogamicin in the treatment of acute myeloid leukemiaFrancis Giles, Elihu Estey, Susan O'Brien
Hematology (Amsterdam, Netherlands)|October 8, 2003
Circulating blasts following chemotherapy in pediatric patients: implications for complete remission definition in acute leukemiaMihaela Onciu, Elihu Estey, Francis J Giles
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
More Versus Less Therapy for Older Adults With Acute Myeloid Leukemia: New Perspectives on an Old DebateHeidi D Klepin, Elihu Estey, Tapan Kadia
Cancer|June 24, 2005
Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndromeChristina A Meyers, Maher Albitar, Elihu Estey
Blood|March 13, 2015
Current challenges in clinical development of "targeted therapies": the case of acute myeloid leukemiaElihu Estey, Ross L Levine, Bob Löwenberg
Leukemia & Lymphoma|June 23, 2017
A case of indolent AML with five-year survival without treatmentEvandro Dantas Bezerra, Heather Smith, Elihu Estey
The New England Journal of Medicine|August 11, 2016
Assessment of Minimal Residual Disease in Standard-Risk AMLMegan Othus, Elihu Estey, Robert P Gale
Leukemia|January 24, 2019
New study-designs to address the clinical complexity of acute myeloid leukemiaElihu Estey, Megan Othus, R P Gale
Pageof 16

Showing results (31-40 of 158) with videos related to

Sort By:
Pageof 16
Hematological Oncology|April 3, 2008
Relevance of clinical trials in acute myeloid leukaemiaApostolia M Tsimberidou, Elihu Estey
Cancer Treatment Reviews|April 3, 2003
Adding arabinosylcytosine to idarubicin induction therapy may not improve survival for people with newly diagnosed acute promyelocytic leukaemiaElihu Estey, Miguel A Sanz
Cancer|November 6, 2003
Gemtuzumab ozogamicin in the treatment of acute myeloid leukemiaFrancis Giles, Elihu Estey, Susan O'Brien
Hematology (Amsterdam, Netherlands)|October 8, 2003
Circulating blasts following chemotherapy in pediatric patients: implications for complete remission definition in acute leukemiaMihaela Onciu, Elihu Estey, Francis J Giles
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
More Versus Less Therapy for Older Adults With Acute Myeloid Leukemia: New Perspectives on an Old DebateHeidi D Klepin, Elihu Estey, Tapan Kadia
Cancer|June 24, 2005
Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndromeChristina A Meyers, Maher Albitar, Elihu Estey
Blood|March 13, 2015
Current challenges in clinical development of "targeted therapies": the case of acute myeloid leukemiaElihu Estey, Ross L Levine, Bob Löwenberg
Leukemia & Lymphoma|June 23, 2017
A case of indolent AML with five-year survival without treatmentEvandro Dantas Bezerra, Heather Smith, Elihu Estey
The New England Journal of Medicine|August 11, 2016
Assessment of Minimal Residual Disease in Standard-Risk AMLMegan Othus, Elihu Estey, Robert P Gale
Leukemia|January 24, 2019
New study-designs to address the clinical complexity of acute myeloid leukemiaElihu Estey, Megan Othus, R P Gale
Pageof 16